Wipfli Financial Advisors LLC Makes New Investment in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Wipfli Financial Advisors LLC purchased a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,454 shares of the company’s stock, valued at approximately $72,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Advisor Group Holdings Inc. raised its position in shares of Prestige Consumer Healthcare by 10.9% in the first quarter. Advisor Group Holdings Inc. now owns 3,694 shares of the company’s stock valued at $196,000 after purchasing an additional 363 shares during the period. JPMorgan Chase & Co. raised its position in shares of Prestige Consumer Healthcare by 10.8% in the first quarter. JPMorgan Chase & Co. now owns 210,242 shares of the company’s stock valued at $11,130,000 after purchasing an additional 20,496 shares during the period. Raymond James & Associates raised its position in shares of Prestige Consumer Healthcare by 84.8% in the first quarter. Raymond James & Associates now owns 9,326 shares of the company’s stock valued at $494,000 after purchasing an additional 4,279 shares during the period. US Bancorp DE raised its position in shares of Prestige Consumer Healthcare by 67.7% in the first quarter. US Bancorp DE now owns 10,237 shares of the company’s stock valued at $541,000 after purchasing an additional 4,132 shares during the period. Finally, HighTower Advisors LLC raised its position in shares of Prestige Consumer Healthcare by 6.0% in the first quarter. HighTower Advisors LLC now owns 5,791 shares of the company’s stock valued at $307,000 after purchasing an additional 330 shares during the period. 99.98% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on PBH shares. Canaccord Genuity Group started coverage on shares of Prestige Consumer Healthcare in a research report on Thursday, November 17th. They issued a “buy” rating and a $71.00 price objective on the stock. Oppenheimer upped their price target on shares of Prestige Consumer Healthcare from $63.00 to $72.00 and gave the company an “outperform” rating in a research note on Friday. StockNews.com assumed coverage on shares of Prestige Consumer Healthcare in a research note on Wednesday, October 12th. They issued a “buy” rating on the stock. Finally, Canaccord Genuity Group assumed coverage on shares of Prestige Consumer Healthcare in a research note on Wednesday, November 16th. They issued a “buy” rating and a $71.00 price target on the stock. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $71.00.

Prestige Consumer Healthcare Trading Up 1.3 %

Shares of Prestige Consumer Healthcare stock opened at $66.62 on Friday. The company has a market capitalization of $3.30 billion, a price-to-earnings ratio of 16.17, a PEG ratio of 1.97 and a beta of 0.57. The company has a quick ratio of 1.29, a current ratio of 2.21 and a debt-to-equity ratio of 0.89. Prestige Consumer Healthcare Inc. has a 12-month low of $48.51 and a 12-month high of $67.18. The firm’s 50-day moving average price is $61.53 and its two-hundred day moving average price is $57.03.

Prestige Consumer Healthcare (NYSE:PBH – Get Rating) last announced its quarterly earnings data on Thursday, November 3rd. The company reported $1.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.02. The firm had revenue of $289.27 million for the quarter, compared to the consensus estimate of $282.93 million. Prestige Consumer Healthcare had a net margin of 18.83% and a return on equity of 12.88%. On average, analysts forecast that Prestige Consumer Healthcare Inc. will post 4.2 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

(Get Rating)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.